diallyl disulfide has been researched along with Lymph Node Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, XH; Jiang, H; Ling, H; Liu, F; Ma, YH; Su, B; Su, J; Su, Q; Wu, YH; Xia, H; Yang, BM; Zeng, X; Zeng, Y; Zhang, S; Zhou, ZG | 1 |
| Hioki, K; Kiuchi, K; Nakagawa, H; Senzaki, H; Tanaka, K; Tsubura, A; Tsuta, K | 1 |
2 other study(ies) available for diallyl disulfide and Lymph Node Metastasis
| Article | Year |
|---|---|
Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
Topics: Allyl Compounds; Animals; Antigens, CD34; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cofilin 1; Disulfides; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Ki-67 Antigen; Lim Kinases; Lymphatic Metastasis; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; p21-Activated Kinases; rac1 GTP-Binding Protein; rho-Associated Kinases; Stomach Neoplasms; Tissue Inhibitor of Metalloproteinase-3; Transplantation, Heterologous; Vimentin | 2016 |
Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.
Topics: Allyl Compounds; Animals; Antineoplastic Agents; Apoptosis; Arachidonic Acids; Breast Neoplasms; Cell Division; Diet; Disulfides; Drug Synergism; Female; Flow Cytometry; Growth Inhibitors; Humans; Inhibitory Concentration 50; Linoleic Acid; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, Estrogen; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |